| pubmed-article:21656739 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C1516238 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0281361 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C1518409 | lld:lifeskim |
| pubmed-article:21656739 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21656739 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:21656739 | pubmed:dateCreated | 2011-6-9 | lld:pubmed |
| pubmed-article:21656739 | pubmed:abstractText | The purpose of this study was to assess the efficacy and safety of 5-fluorouracil (5FU) and gemcitabine administered concurrently with radiation in patients with locally advanced, nonmetastatic pancreatic cancer. | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21656739 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21656739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21656739 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21656739 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21656739 | pubmed:issn | 1097-0142 | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:Cancer and... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:HollisDonnaD | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:MayerRobert... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:FuchsCharles... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:NiedzwieckiDo... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:GoldbergRicha... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:BlackstockA... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:TepperJoel... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:TanBenjamin... | lld:pubmed |
| pubmed-article:21656739 | pubmed:author | pubmed-author:MamonHarvey... | lld:pubmed |
| pubmed-article:21656739 | pubmed:copyrightInfo | Copyright © 2010 American Cancer Society. | lld:pubmed |
| pubmed-article:21656739 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21656739 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21656739 | pubmed:volume | 117 | lld:pubmed |
| pubmed-article:21656739 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21656739 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21656739 | pubmed:pagination | 2620-8 | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:meshHeading | pubmed-meshheading:21656739... | lld:pubmed |
| pubmed-article:21656739 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21656739 | pubmed:articleTitle | A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003. | lld:pubmed |
| pubmed-article:21656739 | pubmed:affiliation | Dana Farber Cancer Institute, Boston, Massachusetts; Brigham and Women's Hospital, Boston, MA 02115, USA. hmamon@lroc.harvard.edu | lld:pubmed |
| pubmed-article:21656739 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21656739 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:21656739 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
